Martin Gleave

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 29 papers. Top paper: “The 5-Hydroxymethylcytosine Landscape of Prostate Cancer”.

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0.635DataRank · unranked

68 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Framework for the Pathology Workup of Metastatic Castration-Resistant Prostate Cancer Biopsies

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-2061

N/A

0.500DataRank · unranked

27 citations

Michael J. Morris, Chien‐Kuang Cornelia Ding, Erolcan Sayar, Rohit Mehra, Brian D. Robinson +10 more

Development and validation of a quantitative reactive stroma biomarker (qRS) for prostate cancer prognosis

Human Pathology(2022)10.1016/j.humpath.2022.01.009

N/A

0.489DataRank · unranked

25 citations

Yan Gao, Yi Ding, Ping Bu, Brian J. Miles, Angelo De Marzo +25 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0.457DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more

Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study

Modern Pathology(2023)10.1016/j.modpat.2023.100241

N/A

0.330DataRank · unranked

8 citations

Stephanie A. Harmon, Rachael Iseman, Olga Ludkowski, Heidi Auman, Sarah T. Hawley +28 more

Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer

Scientific Reports(2024)10.1038/s41598-024-57854-w

N/A

0.307DataRank · unranked

4 citations

Liangliang Liu, Michael Hsing, Kush Dalal, Daksh Thaper, Brian McConeghy +9 more

ABI1 regulates transcriptional activity of Androgen Receptor by novel DNA and AR binding mechanism

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.26.542350

N/A

0.241DataRank · unranked

4 citations

Xiang Li, Neeru Arya, Fan Zhang, Sonia H.Y. Kung, Ladan Fazli +18 more

Identifying Rare Germline Variants Associated with Metastatic Prostate Cancer Through an Extreme Phenotype Study

medRxiv(2025)10.1101/2025.04.28.25326584

N/A

0.104DataRank · unranked

1 citations

Hamideh Sharifi Noghabi, Stanislav Volik, Robert H. Bell, Funda Sar, Anne Haegert +29 more

BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction

Nature Communications(2025)10.1038/s41467-025-67329-9

N/A

0.104DataRank · unranked

1 citations

Sudeep Khadka, Majid Pornour, Hyunju Ryu, Hegang Chen, Arif Hussain +8 more

Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer

Nature Communications(2022)10.1038/s41467-022-32530-7

N/A

0DataRank · unranked

19 citations

Chris Kedong Wang, Htoo Zarni Oo, Irina Nelepcu, Nada Lallous, Charlotte B. Spliid +21 more

Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance

Cancer Medicine(2022)10.1002/cam4.4778

N/A

0DataRank · unranked

10 citations

Lisa F. Newcomb, Kehao Zhu, Yingye Zheng, Hilary Boyer, Navonil De Sarkar +16 more

Correlation of ABI1 and PTEN expression during prostate tumor progression.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.172

N/A

0DataRank · unranked

0 citations

Anita Hryniewicz‐Jankowska, Xiang Li, Katarzyna Augoff, Csaba Papp, Disharee Das +11 more

Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancer

Oncogene(2023)10.1038/s41388-022-02566-6

N/A

0DataRank · unranked

21 citations

Pengfei Xu, Shu Ning, Logan J. Wasielewski, Hans Adomat, Sung Hee Hwang +9 more

Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer

Cancer(2021)10.1002/cncr.33911

N/A

0DataRank · unranked

8 citations

Kehao Zhu, Yingye Zheng, Lisa F. Newcomb, Jeannette M. Schenk, James D. Brooks +15 more

Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad184

N/A

0DataRank · unranked

9 citations

Xiaofei Wang, Evan W. Warner, Andrea Sboner, Matti Annala, Michael Sigouros +13 more

Semaphorin 3C promotes de novo steroidogenesis in prostate cancer cells

Endocrine Related Cancer(2023)10.1530/erc-23-0010

N/A

0DataRank · unranked

3 citations

Satyam Bhasin, Liang Liu, Noushin Nabavi, Chi Wing Cheng, Kevin J. Tam +13 more

Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer

Nature Communications(2021)10.1038/s41467-021-26612-1

N/A

0DataRank · unranked

36 citations

Aashi Chaturvedi, Sarah A. Munro, Samuel P. Pitzen, Alexander Ling, Weijie Zhang +29 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0DataRank · unranked

38 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

A noncanonical AR addiction drives enzalutamide resistance in prostate cancer

Nature Communications(2021)10.1038/s41467-021-21860-7

N/A

0DataRank · unranked

90 citations

Ting Wei, Zhenqing Ye, Jacob J. Orme, Dong Lin, Haoyue Sheng +10 more

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

Scientific Reports(2024)10.1038/s41598-023-50215-z

N/A

0DataRank · unranked

11 citations

Sarah Hawley, Christian A. Kunder, En‐Chi Hsu, Michelle Shen, Lennart Westphalen +17 more

Evaluation of ChatGPT as a Reliable Source of Medical Information on Prostate Cancer for Patients: Global Comparative Survey of Medical Oncologists and Urologists

Urology Practice(2024)10.1097/upj.0000000000000740

N/A

0DataRank · unranked

5 citations

Andrew J. Armstrong, Eamonn Rogers, Dany Habr, Jochen Walz, Martin Gleave +9 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2500327122

N/A

0DataRank · unranked

3 citations

Shreyas Lingadahalli, Umut Berkay Altıntaş, Ahmet Cingöz, Emirhan Tekoglu, Ivan Pak Lok Yu +18 more

Deciphering the Transcription Factor Landscape in Prostate Cancer Progression: A Novel Approach to Understand NE Transdifferentiation

Advanced Science(2025)10.1002/advs.202404938

N/A

0DataRank · unranked

3 citations

Hui Xue, Xiaohui Zhu, Dong Lin, Zheng Chen, Xin Dong +16 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2303

N/A

0DataRank · unranked

13 citations

Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert E. Reiter, Matthew B. Rettig +17 more

Modeling Androgen Deprivation Therapy–Induced Prostate Cancer Dormancy and Its Clinical Implications

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-1037

N/A

0DataRank · unranked

25 citations

Hui Xue, Fan Mo, Yen-yi Lin, Dong Lin, Nelson K.Y. Wong +16 more